HFCAS OpenIR

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma 期刊论文
BMC CANCER, 2022, 卷号: 22
Authors:  Chen, Xi;  Kong, Haiying;  Luo, Linxiang;  Han, Shuiyun;  Lei, Tao;  Yu, Haifeng;  Guo, Na;  Li, Cong;  Peng, Shuailing;  Dong, Xiaowu;  Yang, Haiyan;  Wu, Meijuan
Favorite  |  View/Download:10/0  |  Submit date:2022/02/14
Hodgkin lymphoma  PD-1 inhibitor  PD-L1 inhibitor  PD-L2  Molecular phenotype  Tumor microenvironment  
Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer 期刊论文
NATURE COMMUNICATIONS, 2021, 卷号: 12
Authors:  Chen, Ming;  Chen, Runzhe;  Jin, Ying;  Li, Jun;  Hu, Xin;  Zhang, Jiexin;  Fujimoto, Junya;  Hubert, Shawna M.;  Gay, Carl M.;  Zhu, Bo;  Tian, Yanhua;  McGranahan, Nicholas;  Lee, Won-Chul;  George, Julie;  Hu, Xiao;  Chen, Yamei;  Wu, Meijuan;  Behrens, Carmen;  Chow, Chi-Wan;  Pham, Hoa H. N.;  Fukuoka, Junya;  Wu, Jia;  Parra, Edwin Roger;  Little, Latasha D.;  Gumbs, Curtis;  Song, Xingzhi;  Wu, Chang-Jiun;  Diao, Lixia;  Wang, Qi;  Cardnell, Robert;  Zhang, Jianhua;  Wang, Jing;  Le, Xiuning;  Gibbons, Don L.;  Heymach, John, V;  Lee, J. Jack;  William, William N., Jr.;  Cheng, Chao;  Glisson, Bonnie;  Wistuba, Ignacio;  Futreal, P. Andrew;  Thomas, Roman K.;  Reuben, Alexandre;  Byers, Lauren A.;  Zhang, Jianjun
Favorite  |  View/Download:10/0  |  Submit date:2022/01/10